The main objective of this study was to determine the frequency of the TP53 R337H variant in patients diagnosed with sporadic breast cancer from the state of Paraná and its association with clinical and histopathological parameters to assess its potential prognostic value in this population. Here, TP53 is linked to breast carcinoma.